Filing Details

Accession Number:
0001437749-22-027849
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-11-21 16:15:22
Reporting Period:
2022-11-18
Accepted Time:
2022-11-21 16:15:22
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1742927 Reviva Pharmaceuticals Holdings Inc. RVPH Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1818246 Purav Patel C/O Reviva Pharmaceuticals Holdings, Inc
19925 Stevens Creek Blvd, Suite 100
Cupertino CA 95014
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock, Par Value $0.0001 Per Share Acquisiton 2022-11-18 3,000 $4.69 43,547 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock, Par Value $0.0001 Per Share 28,742 Indirect By Segura Fund LLC
Common Stock, Par Value $0.0001 Per Share 3,318 Indirect By Buena Vista Fund II, LLC
Footnotes
  1. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.